The Dawn of the Era of Disease Modification in Alzheimer's Disease
Howard Feldman
This session was recorded but consent to publication from the presenter has not yet been received.
About the talk
I have known Howard for many years and he first presented at Science Plus in 2014 on his research at UBC on Alzheimer's… Undoubtedly you, your families and friends have experienced personally the devastation wrought by this complex and pervasive disease. I asked him to give us an update on the research and hopefully the advances in diagnosis and treatment. He will be discussing the current state of research on this complex and unfortunately widespread disease, which will be a major burden on health care and family resources in an aging population. This is a session which is not to be missed.
About the speaker
Howard was one of the leading researchers at UBC before moving to the University of California, San Diego in 2016 as a professor of neurosciences, where he was appointed director of the Alzheimer's Disease Cooperative Study. Prior to joining UCSD, he served as Executive Associate Dean for Research in UBC's Faculty of Medicine and directed the Alzheimer's and Related Disorders Clinic at UBC. Beyond Alzheimer's, he contributed to the discoveries of the progranulin (Nature, 2006) and C9ORF72 (Neuron, 2011) genetic mutations which cause frontotemporal dementia. His honors include UBC's Martin M. Hoffman Award for Excellence in Research and recognition among Thomson Reuters' most highly cited researchers in neuroscience.
We are always looking for recommendations for and introductions to presenters who will appeal to the Science Plus audience. Please send to Ray Schachter at Schachter.ray@gmail.com.